Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
(2024) 13:e230241
Remove the protective foil seal from the vial by lifting the perforated ring and peeling it away
Adenovirus-based therapies Gendicine, the first p53 gene therapy, is a recombinant human p53 adenovirus that was approved in 2003 by the China Food and Drug Administration (CFDA) for the treatment of HNSCC
Key Contraindications Wilsons disease: Individuals with this genetic disorder should strictly avoid GHK-Cu due to the risk of copper accumulation
Hormone & thyroid panels Evaluate hormones such as oestradiol, progesterone, testosterone, TSH and free T4/T3 to identify imbalances
Shipping days are Monday - Thursday
US$ 24.28
US$ 25.20
US$ 25.68
US$ 28.60
